1. Home
  2. ETON

as of 12-05-2025 4:00pm EST

$16.26
$0.55
-3.27%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Chart Type:
Time Range:
Founded: 2017 Country:
United States
United States
Employees: N/A City: DEER PARK
Market Cap: 498.8M IPO Year: 2018
Target Price: $29.67 AVG Volume (30 days): 326.6K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.26 EPS Growth: N/A
52 Week Low/High: $11.09 - $23.00 Next Earning Date: 11-06-2025
Revenue: $70,316,000 Revenue Growth: 102.77%
Revenue Growth (this year): 113.27% Revenue Growth (next year): 36.70%

AI-Powered ETON Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 72.97%
72.97%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Eton Pharmaceuticals Inc. News

ETON Breaking Stock News: Dive into ETON Ticker-Specific Updates for Smart Investing

All ETON News

Share on Social Networks: